News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,253 Results
Type
Article (44156)
Company Profile (440)
Press Release (678656)
Multimedia
Podcasts (83)
Webinars (14)
Section
Business (209304)
Career Advice (2060)
Deals (36099)
Drug Delivery (104)
Drug Development (83989)
Employer Resources (174)
FDA (16620)
Job Trends (15194)
News (354260)
Policy (33375)
Tag
Academia (2664)
Accelerated approval (7)
Adcomms (26)
Allergies (94)
Alliances (51194)
ALS (107)
Alzheimer's disease (1465)
Antibody-drug conjugate (ADC) (165)
Approvals (16595)
Artificial intelligence (305)
Autoimmune disease (30)
Automation (18)
Bankruptcy (373)
Best Places to Work (11894)
BIOSECURE Act (19)
Biosimilars (112)
Biotechnology (331)
Bladder cancer (93)
Brain cancer (32)
Breast cancer (358)
Cancer (2765)
Cardiovascular disease (213)
Career advice (1722)
Career pathing (30)
CAR-T (185)
CDC (27)
Cell therapy (502)
Cervical cancer (21)
Clinical research (68666)
Collaboration (998)
Company closure (3)
Compensation (637)
Complete response letters (24)
COVID-19 (2680)
CRISPR (61)
C-suite (301)
Cystic fibrosis (116)
Data (2824)
Decentralized trials (2)
Denatured (29)
Depression (61)
Diabetes (306)
Diagnostics (6477)
Digital health (22)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (126)
Drug shortages (28)
Duchenne muscular dystrophy (122)
Earnings (88700)
Editorial (44)
Employer branding (21)
Employer resources (149)
Events (117451)
Executive appointments (844)
FDA (18159)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (896)
Gene editing (135)
Generative AI (21)
Gene therapy (387)
GLP-1 (792)
Government (4578)
Grass and pollen (4)
Guidances (179)
Healthcare (19302)
Huntington's disease (29)
IgA nephropathy (39)
Immunology and inflammation (151)
Immuno-oncology (6)
Indications (36)
Infectious disease (2837)
Inflammatory bowel disease (153)
Inflation Reduction Act (12)
Influenza (57)
Intellectual property (112)
Interviews (318)
IPO (16874)
IRA (45)
Job creations (3727)
Job search strategy (1459)
Kidney cancer (13)
Labor market (49)
Layoffs (521)
Leadership (18)
Legal (8080)
Liver cancer (78)
Lung cancer (393)
Lymphoma (196)
Machine learning (9)
Management (58)
Manufacturing (365)
MASH (87)
Medical device (13698)
Medtech (13703)
Mergers & acquisitions (19886)
Metabolic disorders (805)
Multiple sclerosis (97)
NASH (19)
Neurodegenerative disease (122)
Neuropsychiatric disorders (36)
Neuroscience (2140)
NextGen: Class of 2025 (6826)
Non-profit (4582)
Now hiring (45)
Obesity (424)
Opinion (240)
Ovarian cancer (95)
Pain (115)
Pancreatic cancer (108)
Parkinson's disease (184)
Partnered (22)
Patents (280)
Patient recruitment (139)
Peanut (49)
People (59093)
Pharmaceutical (87)
Pharmacy benefit managers (21)
Phase I (21560)
Phase II (30263)
Phase III (22391)
Pipeline (1569)
Policy (187)
Postmarket research (2658)
Preclinical (9265)
Press Release (68)
Prostate cancer (135)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (464)
Real estate (6041)
Recruiting (67)
Regulatory (23097)
Reports (50)
Research institute (2436)
Resumes & cover letters (360)
Rett syndrome (9)
RNA editing (9)
RSV (45)
Schizophrenia (87)
Series A (155)
Series B (104)
Service/supplier (11)
Sickle cell disease (63)
Special edition (21)
Spinal muscular atrophy (152)
Sponsored (32)
Startups (3790)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (57)
The Weekly (52)
Vaccines (770)
Venture capitalists (49)
Weight loss (267)
Women's health (43)
Worklife (17)
Date
Today (146)
Last 7 days (516)
Last 30 days (2486)
Last 365 days (32800)
2025 (15445)
2024 (36370)
2023 (41079)
2022 (52357)
2021 (56867)
2020 (55071)
2019 (47705)
2018 (35931)
2017 (33193)
2016 (32641)
2015 (38646)
2014 (32376)
2013 (27350)
2012 (29456)
2011 (30117)
2010 (28254)
Location
Africa (754)
Alabama (64)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (39798)
Australia (6640)
California (7257)
Canada (2266)
China (646)
Colorado (308)
Connecticut (322)
Delaware (183)
Europe (87368)
Florida (1072)
Georgia (239)
Idaho (58)
Illinois (628)
India (26)
Indiana (350)
Iowa (18)
Japan (213)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (64)
Maryland (1010)
Massachusetts (5477)
Michigan (240)
Minnesota (439)
Mississippi (3)
Missouri (86)
Montana (30)
Nebraska (25)
Nevada (77)
New Hampshire (69)
New Jersey (2019)
New Mexico (30)
New York (2026)
North Carolina (1115)
North Dakota (9)
Northern California (3173)
Ohio (230)
Oklahoma (15)
Oregon (39)
Pennsylvania (1560)
Puerto Rico (16)
Rhode Island (37)
South America (1128)
South Carolina (32)
South Dakota (1)
Southern California (2698)
Tennessee (118)
Texas (1073)
United States (27027)
Utah (214)
Virginia (177)
Washington D.C. (73)
Washington State (628)
West Virginia (4)
Wisconsin (67)
723,253 Results for "pain therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics
May 27, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
June 5, 2025
·
4 min read
Press Releases
Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management
June 5, 2025
·
7 min read
Press Releases
Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain
May 1, 2025
·
9 min read
Press Releases
Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
June 13, 2025
·
2 min read
Pain
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a growing number of alternative approaches. Their ultimate uptake, however, remains to be seen.
February 24, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Abeona Therapeutics® and Lurie Children’s Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
May 15, 2025
·
9 min read
FDA
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum in the fledgling non-opioid pain space.
January 30, 2025
·
4 min read
·
Heather McKenzie
Press Releases
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
April 9, 2025
·
3 min read
Editorial
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by
BioSpace
’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid epidemic.
February 7, 2025
·
3 min read
·
Heather McKenzie
1 of 72,326
Next
